BRACAVENIR: an observational study of expectations and coping in young women with high hereditary risk of breast and ovarian cancer.
Fabrice KwiatkowskiMathilde Gay-BellilePascal DessenneClaire LaquetVéronique BoussionMarie BéguinotMarie-Françoise PetitAnne-Sophie GrémeauCéline VerletCharlotte ChaptalMarilyn BroultSylvie JouvencyMartine DuclosYves-Jean BignonPublished in: Hereditary cancer in clinical practice (2019)
BRACAVENIR was registered in ClinicalTrials.gov with no NCT02705924.